Topamax
Product Images NDC 21695-129

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Topamax (NDC 21695-129). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rebel Distributors Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (202b1a2a 11dc 4c3d Aa53 27512a98a042 01)

FDA Label Image

Figure (202b1a2a 11dc 4c3d Aa53 27512a98a042 02)

FDA Label Image

Figure (202b1a2a 11dc 4c3d Aa53 27512a98a042 03)

FDA Label Image

Topamax 25 mg (202b1a2a 11dc 4c3d Aa53 27512a98a042 04)

FDA Label Image

Topamax 50 mg (202b1a2a 11dc 4c3d Aa53 27512a98a042 05)

FDA Label Image

Topamax 100 mg (202b1a2a 11dc 4c3d Aa53 27512a98a042 06)

Topamax 100 mg (202b1a2a 11dc 4c3d Aa53 27512a98a042 06)
This text appears to be a mix of meaningless text and product identification codes. The text is not readable or usable to generate a description. The product identification codes suggest it may be related to a pharmaceutical product by Ortho-Mones Pharmacescal inc. with the product ID of PT013015.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.